Research

The Center for Magnetic Resonance Research (CMRR) set the stage for exploration of brain imaging with its development of ultrahigh field magnetic resonance imaging and expanded its expertise into spectroscopy. A new NIH initiative, Brain Research Through Advancing Innovative Neurotechnologies®, builds on CMRR's work by using advanced MRI together with other emerging tools that rely on optical imaging and cell labeling. This will provide more detailed, clearer pictures of the brain's circuits.

The Microbiota Therapeutics Program led by Dr. Alexander Khoruts has been the world leader in development and manufacturing of microbiota-based therapeutics over the past decade. Microbiota transplant therapy is effective in treating the serious infection c. difficile. Now, it has been shown to be safe for patients with acute myeloid leukemia—a type of blood cancer—and recipients of hematopoietic cell transplantation. Both groups suffer the combined effects of chemotherapy wiping out gut bacteria and a suppressed immune system, making them vulnerable to infection.

Developed in collaboration with researchers globally, this portable device offers access to Magnetic Resonance Imaging (MRI) in remote and rural areas where MRI scanners are typically unavailable. MRI technology provides crucial insights into the human brain, aiding in medical diagnoses and advancing neuroscience. However, conventional MRI machines are costly, demand specialized facilities and require trained operators. The compact, lightweight portable MRI scanner overcomes these barriers, significantly expanding accessibility.